SEC Filing Document

Company: BIOVENTRIX, INC.
Ticker: 
CIK: 1283259
Filing Type: S-1/A
Document Type: EX-10.4
Date Filed: 2026-03-18
Accession Number: 0001493152-26-010642
Exchange: 
SIC Code: 3841
SIC Description: Surgical & Medical Instruments & Apparatus
URL: https://www.sec.gov/Archives/edgar/data/1283259/000149315226010642/ex10-4.htm

Chunk 6 of 8
Word Count: 1459
Character Count: 9183

Document Content:

known or unknown, fixed or contingent (hereinafter called “Claims”), which the undersigned now has or may hereafter have against the Releasees, or any of them, by reason of any matter, cause, or thing whatsoever from the beginning of time to the date hereof. The Claims released herein include, without limiting the generality of the foregoing, any Claims in any way arising out of, based upon, or related to the employment or termination of employment of the undersigned by the Releasees, or any of them; any alleged breach of any express or implied contract of employment; any alleged torts or other alleged legal restrictions on Releasees’ right to terminate the employment of the undersigned; and any alleged violation of any federal, state or local statute or ordinance including, without limitation, Title VII of the Civil Rights Act of 1964, the Age Discrimination In Employment Act (“ADEA”), the Americans With Disabilities Act.

Claims Not Released. Notwithstanding the foregoing, this general release (the “Release”) shall not operate
to release any rights or claims of the undersigned (i) to payments or benefits under Sections 4(b) of that certain Employment Agreement,
dated as of [March [_], 2026], between the Company and the undersigned (the “Employment Agreement”), with respect
to the payments and benefits provided in exchange for this Release, (ii) to payments or benefits under any equity award agreement between
the undersigned and the Company or as a holder of any securities of the Company, (iii) with respect to Sections 2(b)(v) or 4(a) of the
Employment Agreement, (iv) to accrued or vested benefits the undersigned may have, if any, as of the date hereof under any applicable
plan, policy, practice, program, contract or agreement with the Company, (v) to any Claims, including claims for indemnification and/or
advancement of expenses arising under any indemnification agreement between the undersigned and the Company or under the bylaws, certificate
of incorporation or other similar governing document of the Company, (vi) to any Claims which cannot be waived by an employee under applicable
law or (vii) with respect to the undersigned’s right to communicate directly with, cooperate with, or provide information to, any
federal, state or local government regulator.

Exceptions. Notwithstanding anything in this Release to the contrary, nothing contained in this Release shall prohibit the undersigned
from (i) filing a charge with, reporting possible violations of federal law or regulation to, participating in any investigation by,
or cooperating with any governmental agency or entity or making other disclosures that are protected under the whistleblower provisions
of applicable law or regulation and/or (ii) communicating directly with, cooperating with, or providing information (including trade
secrets) in confidence to, any federal, state or local government regulator (including, but not limited to, the U.S. Securities and Exchange
Commission, the U.S. Commodity Futures Trading Commission, or the U.S. Department of Justice) for the purpose of reporting or investigating
a suspected violation of law, or from providing such information to the undersigned’s attorney or in a sealed complaint or other
document filed in a lawsuit or other governmental proceeding. Pursuant to 18 USC Section 1833(b), (1) the undersigned will not be held
criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that is made: (x) in confidence
to a federal, state, or local government official, either directly or indirectly, or to an attorney, and solely for the purpose of reporting
or investigating a suspected violation of law; or (y) in a complaint or other document filed in a lawsuit or other proceeding, if such
filing is made under seal and (2) the undersigned acknowledges that an individual who files a lawsuit for retaliation by an employer
for reporting a suspected violation of law may disclose the trade secret to the attorney of the individual and use the trade secret information
in the court proceeding, if the individual files any document containing the trade secret under seal and does not disclose the trade
secret, except pursuant to court order.

Representations. The undersigned represents and warrants that there has been no assignment or other transfer of any interest in
any Claim which the undersigned may have against Releasees, or any of them, and the undersigned agrees to indemnify and hold Releasees,
and each of them, harmless from any liability, Claims, demands, damages, costs, expenses and attorneys’ fees incurred by Releasees,
or any of them, as the result of any such assignment or transfer or any rights or Claims under any such assignment or transfer. It is
the intention of the parties that this indemnity does not require payment as a condition precedent to recovery by the Releasees against
the undersigned under this indemnity.

No Action. The undersigned agrees that if the undersigned hereafter commences any suit arising out of, based upon, or relating
to any of the Claims released hereunder or in any manner asserts against Releasees, or any of them, any of the Claims released hereunder,
then the undersigned agrees to pay to Releasees, and each of them, in addition to any other damages caused to Releasees thereby, all
attorneys’ fees incurred by Releasees in defending or otherwise responding to said suit or Claim. Notwithstanding the foregoing,
this provision shall not apply to any suit or Claim to the extent it challenges the effectiveness of this release with respect to a claim
under the ADEA.

No Admission. The undersigned further understands and agrees that neither the payment of any sum of money nor the execution of
this Release shall constitute or be construed as an admission of any liability whatsoever by the Releasees, or any of them, who have
consistently taken the position that they have no liability whatsoever to the undersigned.

OWBPA. The undersigned agrees and acknowledges that this Release constitutes a knowing and voluntary waiver and release of all
Claims the undersigned has or may have against the Company and/or any of the Releasees as set forth herein, including, but not limited
to, all Claims arising under the Older Worker’s Benefit Protection Act and the ADEA. In accordance with the Older Worker’s
Benefit Protection Act, the undersigned is hereby advised as follows:

a.	the undersigned has read
the terms of this Release, and understands its terms and effects, including the fact that the undersigned agreed to release and forever
discharge the Company and each of the Releasees, from any Claims released in this Release;

b.	the undersigned understands
that, by entering into this Release, the undersigned does not waive any Claims that may arise after the date of the undersigned’s
execution of this Release, including without limitation any rights or claims that the undersigned may have to secure enforcement of
the terms and conditions of this Release;

c.	the undersigned has signed
this Release voluntarily and knowingly in exchange for the consideration described in this Release, which the undersigned acknowledges
is adequate and satisfactory to the undersigned and which the undersigned acknowledges is in addition to any other benefits to which
the undersigned is otherwise entitled;

d.	the Company advises the undersigned
to consult with an attorney prior to executing this Release;

e.	the undersigned has been
given at least [21]-days in which to review and consider this Release. To the extent that the undersigned chooses to sign this Release
prior to the expiration of such period, the undersigned acknowledges that the undersigned has done so voluntarily, had sufficient time
to consider the Release, to consult with counsel and that the undersigned does not desire additional time and hereby waives the remainder
of the [21]-day period; and

f.	the undersigned may revoke
this Release within seven days from the date the undersigned signs this Release and this Release will become effective upon the expiration
of that revocation period if the undersigned has not revoked this Release during such seven-day period. If the undersigned revokes
this Release during such seven-day period, this Release will be null and void and of no force or effect on either the Company or the
undersigned and the undersigned will not be entitled to any of the payments or benefits which are expressly conditioned upon the execution
and non-revocation of this Release. Any revocation must be in writing and sent to [ name ], via electronic mail at [ email address ],
on or before [5:00 p.m. Eastern time] on the seventh day after this Release is executed by the undersigned.

Acknowledgement. The undersigned acknowledges that different or additional facts may be discovered in addition to what is now
known or believed to be true by the undersigned with respect to the matters released in this Release, and the undersigned agrees that
this Release shall be and remain in effect in all respects as a complete and final release of the matters released, notwithstanding any
different or additional facts.